ArticleScientific reports2025
A phased online support program improves self-efficacy and reduces distress in type 2 diabetes patients using mixed methods design.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Traditional interventions are largely offline, lack continuous support, and primarily focus on improving knowledge. This study aimed to explore the feasibility, acceptability, and preliminary effects of a phased online support program for patients with diabetes. A mixed-methods design with convenience sampling was adopted in this study. A total of 27 patients with diabetes were recruited from a tertiary hospital in Hainan Province. The patients underwent a phased online support program. Feasibility was assessed based on recruitment, participation, and retention rates. After the patients received the intervention at the 9-month follow-up, acceptability was assessed using one-on-one semi-structured interviews. The preliminary effects of the program were assessed by observing changes in clinical and psychosocial indicators. A designated researcher collected all the data from January 2022 to March 2023. The recruitment, participation, and retention rates were all over 80%. Participants perceived positive changes after participating in the program; they considered the program to be highly acceptable and expressed eagerness for ongoing support. Significant improvements were observed in HbA1c, fasting blood glucose, blood pressure, blood lipid profile, weight, body mass index, self-efficacy, diabetes distress, diabetes knowledge, self-management behavior, and chronic disease resource utilization at the 12-month follow-up. The phased online support program for patients with diabetes is feasible and acceptable, with promising preliminary results.The study was registered in the Chinese Clinical Trial Registry (ChiCTR2400082136, http//www.chictr.org.cn/, 21/3/2024).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.